HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

Related Keywords

United States , Kumar Budur , Luis Sanay , Paragon Biosciences , Foundation For Prader Willi Research , Exchange Commission , Prnewswire Harmony Biosciences Holdings Inc , Drug Administration , Company Nasdaq , Biosciences Holdings , Prader Willi Research , Aberrant Behavioral , Chief Medical Officer , Secondary Outcomes , Placebo Controlled Signal Detection , Proof Of Concept Study , Prader Willi Syndrome , Caregiver Global Impression , Aberrant Behavior , Hyperphagia Questionnaire , Clinical Trials , Food Safe Zone , About Prader Willi , Full Prescribing Information , Harmony Biosciences , Plymouth Meeting , Private Securities Litigation Reform Act , Annual Report , Biosciences Media Contact , Biosciences Investor Contact ,